Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | The potential of gene-edited effector cell therapy

Maksim Mamonkin • 20 Aug 2020
EBMT 2020
General CAR-T

Maksim Mamonkin, PhD, Baylor College of Medicine, Houston, TX, discusses gene-edited effector cell therapy, and its potential to improve the outcomes of T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Maksim Mamonkin

Using engineered T-cells to suppress acute GvHD and leukemia relapse after alloSCT
2:05
Using engineered T-cells to suppress acute GvHD and leukemia relapse after alloSCT
Maksim Mamonkin • 10 Feb 2023
CAR-T cell therapy for T-cell malignancies: challenges to address and future outlooks
1:51
CAR-T cell therapy for T-cell malignancies: challenges to address and future outlooks
Maksim Mamonkin • 10 Feb 2023
Exploring the potential role of CD7-targeting CAR-T cells for the treatment of T-ALL
2:14
Exploring the potential role of CD7-targeting CAR-T cells for the treatment of T-ALL
Maksim Mamonkin • 10 Feb 2023
CD5 and CD7 directed CAR T-cells for pediatric T-cell malignancies
2:59
CD5 and CD7 directed CAR T-cells for pediatric T-cell malignancies
Maksim Mamonkin • 1 Sep 2020

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals